SAN FRANCISCO (Reuters) - Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.


20


Reuters

Latest News

Times of Israel: Iran’s navy commander threatens to sink US ships

BBC: Whitbread to spin off Costa chain as a separate firm

Daily Mail: Heidi Klum, Alessandra Ambrosio and Charlotte McKinney flaunt legs at Dundas event in Hollywood

Daily Mail: Romania - Factors to watch on April 25

Daily Mail: Video: Meghan Markle attends Anzac Day service with fiance Harry in London

ABC: Durant, Green lead Warriors past Spurs into second round

CTV News: North, South Korea leaders look to control optics at historic summit

Daily Mail: Golden State Warriors march on to Western Conference...

CNN: MSNBC pushes findings that support Joy Reid's claim of fabricated homophobic blog posts

Reuters: Asian shares rattled by rising U.S. yields, cost worries

Reuters: Asian shares rattled by rising U.S. yields, cost worries

Daily Mail: Embiid, Simmons led 76ers from Process to postseason...

Daily Mail: Kim, Moon seek to control optics at their historic summit

Daily Mail: Afghan Taliban announce fresh offensive in apparent...

Daily Mail: Ben Simmons sets sights on next opponent

Reuters: GLOBAL MARKETS-Asian shares rattled by rising U.S. yields, cost worries

Jpost: 7 alleged Mossad spies sentenced in Algerian court

FOX: Kim, Moon seek to control optics at their historic summit

USA Today: Exclusive: Social Security checks are lower than many Americans expect, survey finds

ABC: Melania Trump takes her moment to sparkle in the spotlight

Daily Mail: Police arrest 2 on suspicion of attempted murder before...

Daily Mail: Unjust dessert? Japan demands Koreans wipe map off...

Daily Mail: PRESS DIGEST - Bulgaria - April 25